Patents
Repligen Reports Third Quarter Fiscal Year 2007 Financial Results
Published in Drug Week, March 9th, 2007
Repligen Corporation (NASDAQ: RGEN) today reported results for the third quarter of fiscal year 2007, ended December 31, 2006. Total revenue for the third quarter, consisting primarily of Protein A and SecreFlo(r) sales, was $3,882,000 compared to total revenue of $2,988,000 for the third quarter of fiscal year 2006, an increase of $894,000 or 30%. Gross profit on product revenue for the third quarter of fiscal year 2007 was $2,828,000 compared to $2,141,000 for the third quarter of fiscal year 2006.
Operating expenses for the third quarter of fiscal year 2007 were $4,139,000 compared to $3,394,000 for the same period in fiscal year 2006. This increase in operating...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2007-03-09)
More Articles from Drug Week
- Acne Vulgaris
AndroScience Corporation Enters Clinical Stage - Actavis Group
Actavis Launches Alprazolam ER Tablets in the U.S. - Acute Myelogenous Leukemia
Vion Pharmaceuticals Enters into an Agreement to Sell Convertible Senior Notes and Warrants - Addiction Medicine
Catalyst Pharmaceutical Partners, Inc. Strengthens Scientific Advisory Board With Appointment of Richard A. Rawson, Ph.D. - Adverse Drug Reactions
Auxilium Announces Results from Phase III Trial that Show AA4500 Successful in Treating Dupuytren's Contracture - Adverse Drug Reactions
Dynogen Reports Positive Results in Phase 2 IBS-c Study - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
